Brief: Senzime Q2 EBITDA SEK -23.573 Million
18/07/2025 07:30
Jul 18 (Reuters) - Senzime Q2 sales SEK 25.695 million. Q2 EPS SEK -0.24 Q2 operating expenses SEK 40.207 million Q2 adjusted gross margin 61.8%
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona